Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
'Crammed into a cell with vermin at New Year' - 2RFK Jr.'s handpicked vaccine panel just voted to stop recommending hepatitis B shots for all newborns. Why experts object.
- 3Exploring Programming Greatness: A Survey of \Easy to use Connection points\
- 4Mossad unveils network of Hamas terror infrastructure across Europe
- 5Exhaustive Experiences into Prudent Senior Living in the UK
- She's been a Bond girl and a mutant. Now she's grappling with Hollywood's obsession with 'eternal youth.'
- 'Women on the floor, riddled with bullets': Ex-hostage Rom Braslavski recounts 'horrors' of Oct. 7
- Culinary Joys: Investigating Connoisseur Cooking at Home
- Fiber is something most people could use more of. But experts advise caution with 'fibermaxxing'
- UN chief calls on Yemen's Houthi rebels to free all UN detainees
- The Secret Side of Italy: 12 Underrated Destinations Locals Don’t Want Tourists to Find
- The most effective method to Offset Album Rates with Liquidity Needs
- See the moon shine with Saturn in the southern sky after sunset Dec. 26
- Astronaut on ISS captures spectacular orbital video of zodiacal light, auroras and the Pleiades
